Traphaco JSC 2021 AR2
The report highlights Traphaco's successful business performance in 2021, achieving a consolidated revenue of over 2,160 billion VND and a consolidated profit after tax of 265 billion VND, representing double-digit growth. The company successfully implemented its Business Restructuring Project, separating its herbal and non-herbal business segments to optimize resources. Traphaco was recognized as the only pharmaceutical enterprise in the Top 10 Sustainable Enterprises in Vietnam in 2021. Additionally, the company actively supported the community during the COVID-19 pandemic by donating medical supplies and contributing to the national vaccine fund.
Company: Traphaco JSC
Sector: Health Care
Country: Vietnam
Year: 2021
Type: AR2
Pages: 95
Traphaco JSC
Annual Report
The report highlights Traphaco's successful business performance in 2021, achieving a consolidated revenue of over 2,160 billion VND and a consolidated profit after tax of 265 billion VND, representing double-digit growth. The company successfully implemented its Business Restructuring Project, separating its herbal and non-herbal business segments to optimize resources. Traphaco was recognized as the only pharmaceutical enterprise in the Top 10 Sustainable Enterprises in Vietnam in 2021. Additionally, the company actively supported the community during the COVID-19 pandemic by donating medical supplies and contributing to the national vaccine fund.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Mar 8, 2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Water Consumption
Workplace Fatalities
Employees